Calcium entry and mobilization signaling pathways in ANG II-induced renal vasoconstriction in vivo

American Journal of Physiology

Volumn 270, Issue 3 PART 2, 1996, Pages

  Ruan, Xiaoping ^a   Arendshorst, William J ^a  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

Angiotensin at1 receptor; Dihydropyridine; Glomerulus; Inositol 1,4,5 trisphosphate; Renal circulation; Vascular resistance; Vascular smooth muscle cell; Voltage gated calcium channel

Indexed keywords

1,4 DIHYDRO 2,6 DIMETHYL 5 NITRO 4 [2 (TRIFLUOROMETHYL)PHENYL] 3 PYRIDINECARBOXYLIC ACID METHYL ESTER; ANGIOTENSIN; CALCIUM CHANNEL; CALCIUM ION; NIFEDIPINE;

ANIMAL EXPERIMENT; ARTERY RESISTANCE; ARTICLE; CALCIUM MOBILIZATION; DOSE RESPONSE; INTRACELLULAR TRANSPORT; KIDNEY BLOOD FLOW; NONHUMAN; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION; VASOCONSTRICTION;

ANGIOTENSIN II; ANIMALS; BIOLOGICAL TRANSPORT; CALCIUM; RATS; RATS, INBRED WKY; RENAL CIRCULATION; SIGNAL TRANSDUCTION; VASOCONSTRICTION; VASOCONSTRICTOR AGENTS;

EID: 0029995225     PISSN: 00029513     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajprenal.1996.270.3.f398     Document Type: Article

References (35)

1. Alexander, R. W., T. A. Brock, M. A. Bimbrone, and S. E. Rittenhouse. Angiotensin increases inositol triphosphate and calcium in vascular smooth muscle. Hypertension Dallas 7: 447-451,1985.
2. Bell, A. J and A. Lindner. Effects of verapamil and nifedipine on renal function and hemodynamics in the dog. Renal Physiol. 7: 329-343, 1984.
3. Berridge, M. J. Inositol triphosphate and diacylglycerol as second messengers. Biochem. J. 220: 345-360, 1984.
4. Carmines, P. K., B. C. Fowler, and P. D. Bell. Segmentally distinct effects of depolarization on intracellular |Ca2 + ] in renal arterioles. Am. J. Physiol. 265 (Renal Fluid Electrolyte Physiol. 34): F677-F685,1993.
5. Carmines, P. K., and L. G. Navar. Disparate effects of Ca channel blockade on afferent and efferent arteriolar responses to ANG II. Am. J. Physiol. 256 (Renal Fluid Electrolyte Physiol. 25): F1015-F1020, 1989.
6. Chatziantoniou, C., and W. J. Arendshorst. Angiotensin receptor sites in renal vasculature of rats developing genetic hypertension. Am. J. Physiol. 265 (Renal Fluid Electrolyte Physlol. 34): F853-F862,1993.
7. Chatziantoniou, C., F. H. Daniels, and W. J. Arendshorst. Exaggerated renal vascular reactivity to angiotensin and thromboxane in young genetically hypertensive rats. Am. J. Physiol. 259 (Renal Fluid Electrolyte Physiol. 28): F372-F382, 1990.
8. Chatziantoniou, C., X. Ruan, and W. J. Arendshorst. Defective G-protein activation of the cAMP pathway in rat kidney during genetic hypertension. Proc. Natl. Acad. Sei. USA 92: 2924-2928,1995.
9. Chiou, C. Y., and M. H. Malagodi. Studies on the mechanism of action of a new Ca2+ antagonist, 8-W,JV-diethlamino)octyl-3,4,5trimethoxyxbenzoate hydrochloride in smooth and skeletal muscles. Br. J. Pharmacol. 53: 279-285, 1975.
10. Cooper, C. L., J. E. Shaffer, and K. U. Malik. Mechanism of action of angiotensin II and bradykinin on prostaglandin synthesis and vascular tone in the isolated rat kidney. Circ. Res. 56: 97-108, 1985.
11. Conger, J. D., and S.A. Falk. KC1 and angiotensin responses in isolated rat renal arterioles: effects of diltiazem and low calcium medium. Am. J. Physiol. 264 (Renal Fluid Electrolyte Physiol. 33): F134-F140,1993.
12. Fleckstein, A. Specific pharmacology of calcium in myocardium, cardiac pacemakers, and vascular smooth muscle. Annu. Rev. Pharmacol. Toxicol. 17: 149-166, 1977.
13. Fleming, J. T., N. Parekh, and M. Steinhausen. Calcium antagonists preferentially dilate preglomerular vessels of hydronephrotic kidney. Am. J. Physiol. 253 (Renal Fluid Electrolyte Physiol. 22): F1157-F1163, 1987.
14. Ghosh, T. K., P. S. Eis, J. M. Mullaney, C. L. Ebert, and D. L. Gill. Competitive, reversible, and potent antagonist of 1,4,5trisphosphate-activated calcium release by heparin. J. Biol. Chem. 263: 11075-11079,1988.
15. Goldberg, J. P., and R. W. Schrier. Effect of calcium membrane blockers on in vivo vasoconstrictor properties of norepinephrine, angiotensin II and vasopressin. Miner. Electrolyte Metab. 10: 178-183, 1984.
16. Ichikawa, T., J. F. Miele, and B. Brenner. Reversal of renal cortical actions of angiotensin II by verapamil and manganese. Kidney Int. 16: 137-147, 1979.
17. Kobayashi, S., A. V. Somlyo, and A. P. Somlyo. Heparin inhibits the inositol 1,4,5-trisphosphate-dependent, but not the independent, calcium release induced by guanine nucleotide in vascular smooth muscle. Biochem. Biophys. Res. Commun. 153: 625-631, 1988.
18. Loutzenhiser, R., and M. Epstein. Effects of calcium channel antagonists on renal hemodynamics. Am. J. Physiol. 249 (Renal Fluid Electrolyte Physiol. 18): F619-F629, 1985.
19. Loutzenhiser, R., K. Hayashi, and M. Epstein. Divergent effects of KCl-induced depolarization on afferent and efferent arterioles. Am. J. Physiol. 257 (Renal Fluid Electrolyte Physiol. 26): F546-F564, 1989.
20. Mahieu, P. R., J. B. Foidart, C. H. Dubois, C. A. Dechenne, and J. Deheneffe. Tissue culture of normal rat glomeruli contractile activity of the cultured mesangial cells. Invest. Cell Pathol. 3: 121-128, 1980.
21. McDermott, G. F., R. D. Hurst, and C. I. Whiteside. Isolated rat glomerular cells demonstrate L-type Ca2+-channel activity. Cell Calcium 14: 387-396, 1993.
22. Mitchell, K., and L. G. Navar. Tubuloglomerular feedback responses during peritubular infusions of calcium channel blockers. Am. J. Physiol. 258 (Renal Fluid Electrolyte Physiol. 27): F537-F544, 1990.
23. Muller-Suur, R., H. U. Gutsche, and H. J. Schurek. Acute and reversible inhibition of tubuloglomerular feedback mediated afferent vasoconstriction by the calcium-antagonist verapamil. Curr. Probl. Clin. Biochem. 6: 291-298, 1976.
24. Nabika, T., P. A. Velletri, W. Lovenberg, and M. A. Beaven. Increase in cytosolic calcium and phosphoinositide metabolism induced by angiotensin II and [Arg] vasopressin in vascular smooth muscle cells. J. Biol. Chem. 260: 4661- 4670,1985.
25. Navar, L. G., W. J. Champion, and C. E. Thomas. Effects of calcium channel blockade on renal vascular resistance responses to changes in perfusion pressure and angiotensin-converting enzyme inhibition in dogs. Circ. Res. 58: 874-881, 1986.
26. Ogawa, N., H. Kushida, and S. Satoh. Effect of verapamil on renal vasoconstriction induced by angiotensin II, norepinephrine, or renal nerve stimulation in anesthetized dogs. Arch. Pharmacodyn. Ther. 268: 113-121, 1984.
27. Ogawa, N., and H. Ono. Role of Ca channel in the renal autoregulatory vascular response analyzed by the use of BAY K 8644. Naunyn-Schmledeberg's Arch. Pharmacol. 335: 189-193, 1987.
28. Ogawa, N., and H. Ono. Effect of 8-(JV,./V-diethylamino)octyl3,4,5-trimetoxybenzoate (TMB-8), an inhibitor of intracellular Ca2 ' release, on autoregulation of renal blood flow in the dog. Naunyn-Schmiedeberg'sArch. Pharmacol. 338: 293-296, 1988.
29. Ruegg, U. R., A. Wallnofer, S. Weir, and C. Cauvin. Receptoroperated calcium-permeable channels in vascular smooth muscle. J. Cardiovasc. Pharmacol. 14, Suppl. 6: S49-S58, 1989.
30. Schramm, M., G. Thomas, R. Towart, and G. Franckowiak. Novel dihydropyridines with positive inotropic action through activation of Ca2 channels. Nature Land. 303: 535-537, 1983.
31. Simonson, M. S., and M. J. Dünn. Ça2 signalling by distinct endothelin peptides in glomerular mesangial cells. Exp. Cell. Res. 192: 148-156, 1991.
32. Smith, J. B., L. Smith, E. R. Brown, D. Barnes, M. A. Sabir, J. S. Davis, and R. V. Farese. Angiotensin II rapidly increase phosphatide-phosphoinositide synthesis and phosphoinositide hydrolysis and mobilizes intracellular calcium in cultured arterial muscle cells. Proc. Natl. Acad. Sei. USA 81: 7812-7816. 1984.
33. Takahara, A., M. Suzuki-Kusaba, H. Isa, and S. Satoh. Effects of a novel Ca21 entry blocker, CD-349, and TMB-8 on renal vasoconstriction induced by angiotensin II and vasopressin in dogs. J. Cardiovasc. Pharmacol. 16: 966-970, 1990.
34. Takeda, K., H. Meyer-Lehnert, J. K. Kirn, and R. W. Schrier. Effect of angiotensin II on Ca2kinetics and contraction in cultured rat glomerular mesangial cells. Am. J. PhysioJ. 254 (Renal Fluid Electrolyte Physiol. 23): F254-F266, 1988.
35. Xiong, Z., and N. Sperelakis. Regulation of L-type calcium channels of vascular smooth muscle cells. J. Mol. Cell Cardiol. 27:75-91, 1995.